Home
People
Publications
News & Events
Funding
Contact

Bivona Lab

Home
People
Publications
News & Events
Funding
Contact
Lab Bivona
September 14, 2017

Efficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling oncogenic RAS, RAS-GTP dependent oncogenic BRAF and NF1 loss

Lab Bivona
September 14, 2017

Source:https://www.biorxiv.org/content/10.1101/188730v1"target="_blank

Newer PostEvolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Older PostInactivation of Capicua drives cancer metastasis.
Back to Top
Home
People
Publications
News & Events
Funding
Contact